Prenatal exposure to phenytoin, facial development, and a possible role for vitamin K

Area of Science:

• Teratology
• Developmental Biology
• Clinical Genetics

Background:

• Maxillonasal hypoplasia, also known as Binder syndrome, presents with characteristic facial anomalies.
• Prenatal exposure to anticonvulsants, particularly phenytoin, has been linked to various birth defects.
• Vitamin K deficiency is a known teratogen that can affect cartilage and bone development.

Purpose of the Study:

• To investigate the association between prenatal anticonvulsant exposure and maxillonasal hypoplasia.
• To explore the role of vitamin K deficiency in the pathogenesis of Binder syndrome.
• To propose a preventive strategy for anticonvulsant-induced facial abnormalities.

Main Methods:

• Retrospective identification of ten patients with maxillonasal hypoplasia and prenatal phenytoin exposure.
• Radiographic assessment of neonates to identify characteristic calcifications.
• Review of clinical evidence linking anticonvulsant use, vitamin K deficiency, and facial malformations.

Main Results:

• Six of ten patients exhibited punctate calcification, indicative of chondrodysplasia punctata.
• Facial abnormalities are hypothesized to result from anticonvulsant-induced vitamin K deficiency.
• Abnormal development of the cartilaginous nasal septum is implicated as the cause of hypoplasia.

Conclusions:

• Anticonvulsant-induced vitamin K deficiency may cause maxillonasal hypoplasia.
• Early vitamin K supplementation during pregnancy is proposed as a preventive measure.
• Maxillonasal hypoplasia can lead to severe disfigurement and significant emotional distress, necessitating long-term surgical and dental interventions.